InTouch Indexed in Medline and Index Medicus

Publication
Article
OncologyONCOLOGY Vol 16 No 6
Volume 16
Issue 6

InTouch magazine, a sister publication of ONCOLOGY and Oncology News International, has been selected by the National Library of Medicine to be indexed and included in Index Medicus and Medline. InTouch is published by PRR for cancer patients and their families.

InTouch magazine, a sister publicationof ONCOLOGY and Oncology News International, has been selected by the NationalLibrary of Medicine to be indexed and included in Index Medicus and Medline. InTouch is published by PRR for cancer patients and their families.

"It’s a real tribute to the editorial quality of InTouch," said Steven T. Rosen, MD. Dr. Rosen, director of the Robert H.Lurie Comprehensive Cancer Center, serves as medical editor-in-chief for InTouch,which just celebrated its third year of publication.

The National Library of Medicine looks to an advisorycommittee—the Literature Selection Technical Review Committee—to choosejournals and other publications for citation. Composed of authoritiesknowledgeable in the field of biomedicine, the committee includes physicians,researchers, educators, editors, health science librarians, and historians whoreview and recommend titles for indexing. The databases in the Medlars system inwhich InTouch will appear are Index Medicus and Medline. These databases areavailable online internationally.

"We’re delighted that the NLM has recognized the integrity and valueof the information in InTouch," said Dr. Rosen. "Their endorsementfurthers our mission, which is to give patients and their loved ones the mostauthoritative and up-to-date information on cancer prevention and treatment sothat they can be better informed about their health care."

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Related Content